CompoAtlas

SX-7 #Shatter

Natural health product licensed in Canada

Licence holder
Iovate Health Sciences International Inc.
NPN or DIN-HM
80055523
Status
Active licence
Licence date
7 November 2014
Revision date
Not provided
Form
Poudre
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
1,3,7-Triméthylxanthine

Source : Caféine

160 mg
Aframomum melegueta

Source : Graine(s)

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 100 mg

20 mg

Non-medicinal ingredients

Pink lemonade flavour, rouge de betterave, Acesulfame Potassium, Rouge Allura AC, Blue raspberry flavor, Poly(dextrose), Watermelon flavour, Chlorure de sodium, Bleu brilliant FCF, Sucralose, Acide citrique, Saveur de punch aux fruits, Acide DL-malique, Calcium Silicate

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 yearsminimum: 1 Mesures ; maximum: 2 Mesures1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps increase lean mass when used in conjunction with a resistance training regimen and a healthy balanced diet. Helps improves strength and performance in repetitive bouts of brief, highly intense physical activity and a health balanced diet.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80055523

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line